Parkinson's Disease

Our series of artists and educators connecting arts and humanities to medicine continues with UNLV Ph.D. candidate Robert Cochrane's talk on how improv can help Parkinson's patients. Series: "Let's Jam: The Arts in Medicine" [Health and Medicine] [Humanities] [Arts and Music] [Show ID: 37988]

Discover how experts in cell biology are partnering with a pioneer in imaging technology to develop a personalized approach to treating Parkinson’s disease. Series: "Innovations Shaping the Future of Parkinson's Disease Treatment " [Health and Medicine] [Show ID: 37040]

Hear directly from the team that developed the groundbreaking ability to make new, healthy neurons that can replace those lost in Parkinson’s disease and their vision to turn their discovery into a life-changing therapy. Series: "Innovations Shaping the Future of Parkinson's Disease Treatment " [Health and Medicine] [Show ID: 37041]

Hear how a team of interdisciplinary experts solved the structure of LRRK2, a gene found to be mutated in Parkinson’s disease, and how their discovery is guiding the way for new targeted therapeutics. Series: "Innovations Shaping the Future of Parkinson's Disease Treatment " [Health and Medicine] [Show ID: 37039]

Learn how social workers and a patient advocate are partnering to develop a suite of free support programs and services for Parkinson's disease patients and their care partners in San Diego. Series: "Innovations Shaping the Future of Parkinson's Disease Treatment " [Health and Medicine] [Show ID: 37038]

Irene Litvan, MD Joseph Wang, MD explain how experts are collaborating across disciplines to adapt wearable technology to automate medication management, offering a greater quality of life for individuals with Parkinson’s disease. Series: "Innovations Shaping the Future of Parkinson's Disease Treatment " [Health and Medicine] [Show ID: 37037]

Xiang Dong Fu, PhD shares the findings of his paper published in the June 24, 2020 issue of Nature. By investigating a strategy to directly convert astrocytes to dopaminergic (DA) neurons in the substantia nigra, the research shows a potentially powerful and clinically feasible approach to treating neurodegeneration by replacing lost neurons. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36179]

Irene Litvan, MD; Don Cleveland, PhD; and David Higgins, PhD, discuss the next generation of treatments for Parkinson's Disease and offer a patient's perspective in this conversation on the cutting edge stem cell research. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36076]

Irene Litvan, MD, FAAN, FANA, Director of UC San Diego’s Movement Disorder Program, discusses the latest advances in detection and treatment of Parkinsonian Disorders including examples of her fascinating work in PSP and Parkinson’s disease. She will also provide practical advice for reducing the risk of developing these disorders. Series: "Stein Institute for Research on Aging" [Health and Medicine] [Show ID: 30569]

Parkinson's disease (PD) affects more than a million people in the US. Jeanne Loring, professor and the founding director of the Center for Regenerative Medicine at The Scripps Research Institute in La Jolla, discusses current research and potential future therapies for PD. In 2012, a partnership of scientists, clinicians, PD patients, and patient advocates was formed to develop a therapy for PD using patients' own skin cells that can be transformed into dopamine neurons, which can then be transplanted to their brains to restore lost cells. With further support from the foundation and granting agencies, the research and clinical partners hope to transplant cells to the first patient in about three years. This kind of partnership is unprecedented, and is inspiring for both the researchers and the patients, who are working together to develop the first effective therapy for PD. Series: "Exploring Ethics" [Health and Medicine] [Show ID: 30484]